| 6.59 Delayed Data As of Mar 05 |  +0.29 / +4.60%Today’s Change | 5.06 Today|||52-Week Range 13.18 | -5.86% Year-to-Date |
| Previous close | 6.30 |
| Today’s open | 6.30 |
| Day’s range | 6.29 - 6.68 |
| Volume | 418,281 |
| Average volume (3 months) | 673,053 |
| Market cap | $98.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +33.68% |
| Earnings growth (this year) | -153.33% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.85 |
| Today’s change | Today’s % change | |
|---|---|---|
| OCRXOcera Therapeutics I... | -0.09 | -1.80% |
| LPCNLipocine Inc | +0.26 | +3.27% |
| NERVMinerva Neuroscience... | +0.38 | +7.31% |
| ITEKInotek Pharmaceutica... | -0.00 | -0.08% |
| Next reporting date | March 12, 2015 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.6M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Steven J. Mento |
Chief Financial Officer, Secretary & SVP-Finance Charles J. Cashion |
Corporate headquarters San Diego, California |
